Wearable Sensors Market to Reach $13.2 billion, Globally, by 2034 at 21.4% CAGR: Allied Market Research
The global wearable sensors market is experiencing rapid growth due to rise in integration of wearable sensors with smartphones and...
Brain
TEDCO’s Maryland Innovation Initiative Announces Recent Company Formation and Technology Assessment Awardees
Maryland Innovation Initiative awards more than $2 million across 14 projects COLUMBIA, Md., Nov. 10, 2025 /PRNewswire/ -- TEDCO, Maryland's...
Brainomix Recognized in Global Health Tech Competition for Its Innovative Brainomix 360 Stroke Technology
Company earns top recognition in the Science category for its stroke AI technology CHICAGO and OXFORD, England, Nov. 10, 2025...
Zenos Health Summit 2025 Concludes Transformative Three-Day Gathering of Global Longevity Leaders in Riyadh
Over 1,000 Global Leaders Convene for Inaugural Summit as Saudi Arabia Emerges as Hub for Wellness Innovation and Longevity Science...
Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks
NAPERVILLE, IL / ACCESS Newswire / November 10, 2025 / Brain Balance, a leading brain health and development program that...
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront M42,...
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated: 59% risk reduction in ACM in...
MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era
Boost memory, focus & mental clarity with MemoMaster – a clinically inspired brain supplement for sharper thinking, sustained energy &...
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% reduction in vomiting...
Hone Health Integrates Prenuvo Whole-Body MRI Scans to Power Preventive, Data-Driven Longevity Care
NEW YORK, Nov. 6, 2025 /PRNewswire/ --Â Hone Health, the leader in longevity intelligence and personalized care, is teaming up with...
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
DOVER, Del., Nov. 6, 2025 /PRNewswire/ --Â Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies...
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use...
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
Society for Neuroscience Annual Meeting, November 15-19, San Diego, CAWALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global...
The Michael J. Fox Foundation for Parkinson’s Research Applauds Texas Voters on Passage of Proposition 14 Securing $3 Billion for Brain Disease Research
The ballot measure was supported by national and local neurodegenerative disease organizations, including The Michael J. Fox Foundation (MJFF). MJFF...
SarahCare Adult Day Center of Jenkintown Launches New Korean Program: Welcoming the Korean Community to an Enriching, Supportive, Social Environment
JENKINTOWN, PA / ACCESS Newswire / November 5, 2025 / SarahCare Adult Day Center of Jenkintown is thrilled to announce...
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a...
Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
WESTBROOK, Maine, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company,...
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
New NIH grant awards $2.5 million over 5 years for mechanistic studyBURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE)...
“Nobel Prize in Neurosurgery” Winner Dr. Aaron Cohen-Gadol Launches Revolutionary AI Platform Covering 35 Medical Specialties
ATLAS GPT Brings Award-Winning Surgical Excellence to Transform Clinical Decision-Making Across All Healthcare Disciplines LOS ANGELES, Nov. 4, 2025 /PRNewswire/...